Eligibility for Newer Biologic Therapies in Severe Asthma, Re-analysis of the Identification and Description of sEvere Asthma patients in a cross-sectionaL (IDEAL) Study
D. Hinds, D. Gibbons, N. Gunsoy, M. Stott-Miller, F. Albers
{"title":"Eligibility for Newer Biologic Therapies in Severe Asthma, Re-analysis of the Identification and Description of sEvere Asthma patients in a cross-sectionaL (IDEAL) Study","authors":"D. Hinds, D. Gibbons, N. Gunsoy, M. Stott-Miller, F. Albers","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5926","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":166649,"journal":{"name":"D22. REAL WORLD MEDICATION USE IN PULMONARY DISEASES","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"D22. REAL WORLD MEDICATION USE IN PULMONARY DISEASES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5926","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}